Chemomab Therapeutics Ltd. Restricted Cash and Cash Equivalents
Chemomab Therapeutics Ltd. (CMMB) had Restricted Cash and Cash Equivalents of $0 as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2021-03-09
- 2020-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2020-09-30: Restricted Cash and Cash Equivalents $0.00.
- 2020-06-30: Restricted Cash and Cash Equivalents $0.00.
- 2020-03-31: Restricted Cash and Cash Equivalents $126.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 |
| 2020-03-31 | $126.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $130.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $130.00K 10-Q · filed 2020-11-16 |
| 2019-06-30 | $130.00K 10-Q · filed 2020-08-14 |
| 2019-03-31 | $130.00K 10-Q · filed 2020-05-07 |
| 2018-12-31 | $120.00K 10-K · filed 2020-03-17 |